Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Income from Discontinued Operations (2020 - 2021)

Catheter Precision's (VTAK) quarterly Income from Discontinued Operations came in at -$530000.0 in Q4 2021, down 162.38% year-over-year from $849682.5 in Q4 2020, and down 117.21% quarter-over-quarter from $3.1 million in Q3 2021.

Analysis

Catheter Precision (VTAK) Income from Discontinued Operations (2020 - 2021) Analysis & Trends

Catheter Precision (VTAK) has reported Income from Discontinued Operations for 2 consecutive years, with -$530000.0 the latest figure, recorded in Q4 2021.

  • On a quarterly basis, Income from Discontinued Operations fell 162.38% year-over-year to -$530000.0 in Q4 2021; TTM through Dec 2021 was $2.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $2.2 million, up 402.21% from the prior year.
  • Income from Discontinued Operations was -$530000.0 for Q4 2021 at Catheter Precision, down from $3.1 million in the prior quarter.
  • Over five years, Income from Discontinued Operations peaked at $3.1 million in Q3 2021 and troughed at -$530000.0 in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -530,000.00
Sep 30, 2021 3.08 Mn
Mar 31, 2021 -359,000.00
Dec 31, 2020 -202,000.00
Sep 30, 2020 -264,000.00